期刊文献+

慢性活动性EB病毒感染的研究进展 被引量:5

Research progress of chronic active Epstein-Barr virus infection
原文传递
导出
摘要 机体感染EB病毒(EBV)后,可以表现为持续性或反复发作性发热,肝、脾、淋巴结大,以及肝丙氨酸氨基转移酶水平异常增高等传染性单核细胞增多症(IM)样症状。伴随EBV特异性抗体谱表达与外周血EBV—DNA拷贝数显著增高的EBV感染,称为慢性活动性EB病毒感染(CAEBV)。CAEBV为一种临床少见的致命性疾病,预后凶险,导致的患者病死率极高。目前,CAEBV的发病机制尚未完全阐明,亦无标准治疗方案。笔者拟就CAEBV的发病机制、临床表现、诊断及治疗研究的最新进展进行综述,旨在提高临床医师对CAEBV的认识。 Epstein-Barr virus (EBV) infection is characterized as chronic or recurrent infectious mononucleosis (IM)-like symptoms, such as fever, extensive lymphadenopathy, hepatosplenomegaly and persistent hepatitis. Additionally, the expression of EBV specific antibody spectrum and a significant incrcase of EBV DNA copies are often demonstrated in peripheral blood of patients with chronic active Epstein-Barr virus infection (CAEBV). CAEBV is a rare fatal disease with poor prognosis and high mortality. The pathogenesis of CAEBV is unknown and there is no standarlized treatment. In order to improve understanding of CAEBV in the clinical work, this article summarizes the pathogenesis, clinical features, diagnose and therapies of CAEBV.
出处 《国际输血及血液学杂志》 CAS 2017年第3期269-272,共4页 International Journal of Blood Transfusion and Hematology
关键词 EB病毒感染 诊断 疗法 Epstein-Barr virus infections Diagnosis Therapeutics
  • 相关文献

参考文献8

二级参考文献51

  • 1洪亮,金嘉琳,张文宏,丁继光,翁心华.成人慢性活动性eb病毒感染三例分析[J].中华临床感染病杂志,2012,5(2):101-103. 被引量:9
  • 2朱慧明,吴铁,崔燎.阿司匹林诱导人肺腺癌细胞株SPCA-1凋亡研究[J].中国药理学通报,2004,20(6):640-643. 被引量:11
  • 3段红梅,谢正德,申昆玲.慢性活动性EB病毒感染的研究进展[J].临床儿科杂志,2007,25(2):153-156. 被引量:27
  • 4Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection[l]. Am 1 Hematol, 2005,80(1): 64-69.
  • 5Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection[l]. Blood, 2001, 98(2): 280-286.
  • 6Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection[J]. 1 Infect Dis, 2003, 187(4): 527-533.
  • 7Yamashita N, Kimura H, Morishima T. Virological aspects of Epstein-Barr virus infections[J]. Acta Med Okayama, 2005, 59(6): 239-246.
  • 8Okano M. Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome[J]. Crit Rev Oncol Hematol, 2002, 44(3): 273-282.
  • 9CohenJ]. Optimal treatment for chronic active Epstein-Barr virus diseases[l]. Pediatr Transplant, 2009, 13(4): 393-396.
  • 10Gulley ML, Glaser SL, Craig FE, et al. Guidelines for interpreting EBER in situ hybridization and LMPI immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma[J]. AmJ Clin Pathol, 2002, 117(2): 259-267.

共引文献46

同被引文献64

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部